nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CHRNA3—chronic obstructive pulmonary disease	0.366	0.778	CbGaD
Bupropion—CYP1A2—chronic obstructive pulmonary disease	0.104	0.222	CbGaD
Bupropion—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0489	0.138	CbGbCtD
Bupropion—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0489	0.138	CbGbCtD
Bupropion—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0371	0.104	CbGbCtD
Bupropion—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0274	0.0773	CbGbCtD
Bupropion—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0218	0.0613	CbGbCtD
Bupropion—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0183	0.0515	CbGbCtD
Bupropion—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0168	0.0474	CbGbCtD
Bupropion—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0168	0.0474	CbGbCtD
Bupropion—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0159	0.0447	CbGbCtD
Bupropion—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0154	0.0433	CbGbCtD
Bupropion—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0154	0.0433	CbGbCtD
Bupropion—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0137	0.0386	CbGbCtD
Bupropion—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0129	0.0364	CbGbCtD
Bupropion—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0127	0.0359	CbGbCtD
Bupropion—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00872	0.0246	CbGbCtD
Bupropion—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00832	0.0234	CbGbCtD
Bupropion—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00741	0.0209	CbGbCtD
Bupropion—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00435	0.0123	CbGbCtD
Bupropion—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00411	0.0116	CbGbCtD
Bupropion—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	7.7e-05	0.000595	CcSEcCtD
Bupropion—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000594	CcSEcCtD
Bupropion—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	7.68e-05	0.000594	CcSEcCtD
Bupropion—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	7.67e-05	0.000593	CcSEcCtD
Bupropion—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	7.67e-05	0.000592	CcSEcCtD
Bupropion—Skin disorder—Montelukast—chronic obstructive pulmonary disease	7.61e-05	0.000588	CcSEcCtD
Bupropion—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000586	CcSEcCtD
Bupropion—Oedema—Salbutamol—chronic obstructive pulmonary disease	7.55e-05	0.000583	CcSEcCtD
Bupropion—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	7.55e-05	0.000583	CcSEcCtD
Bupropion—Infection—Salbutamol—chronic obstructive pulmonary disease	7.5e-05	0.00058	CcSEcCtD
Bupropion—Hypotension—Formoterol—chronic obstructive pulmonary disease	7.47e-05	0.000577	CcSEcCtD
Bupropion—Hypotension—Arformoterol—chronic obstructive pulmonary disease	7.47e-05	0.000577	CcSEcCtD
Bupropion—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	7.47e-05	0.000577	CcSEcCtD
Bupropion—Pruritus—Aminophylline—chronic obstructive pulmonary disease	7.43e-05	0.000574	CcSEcCtD
Bupropion—Shock—Salbutamol—chronic obstructive pulmonary disease	7.43e-05	0.000574	CcSEcCtD
Bupropion—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	7.42e-05	0.000573	CcSEcCtD
Bupropion—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	7.4e-05	0.000572	CcSEcCtD
Bupropion—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	7.37e-05	0.000569	CcSEcCtD
Bupropion—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	7.33e-05	0.000567	CcSEcCtD
Bupropion—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	7.3e-05	0.000564	CcSEcCtD
Bupropion—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	7.3e-05	0.000564	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	7.29e-05	0.000563	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	7.29e-05	0.000563	CcSEcCtD
Bupropion—Insomnia—Arformoterol—chronic obstructive pulmonary disease	7.23e-05	0.000559	CcSEcCtD
Bupropion—Insomnia—Formoterol—chronic obstructive pulmonary disease	7.23e-05	0.000559	CcSEcCtD
Bupropion—Anorexia—Salbutamol—chronic obstructive pulmonary disease	7.2e-05	0.000556	CcSEcCtD
Bupropion—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	7.19e-05	0.000556	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	7.14e-05	0.000551	CcSEcCtD
Bupropion—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	7.13e-05	0.000551	CcSEcCtD
Bupropion—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	7.13e-05	0.000551	CcSEcCtD
Bupropion—Somnolence—Formoterol—chronic obstructive pulmonary disease	7.11e-05	0.000549	CcSEcCtD
Bupropion—Somnolence—Arformoterol—chronic obstructive pulmonary disease	7.11e-05	0.000549	CcSEcCtD
Bupropion—Insomnia—Montelukast—chronic obstructive pulmonary disease	7.08e-05	0.000547	CcSEcCtD
Bupropion—Hypotension—Salbutamol—chronic obstructive pulmonary disease	7.06e-05	0.000545	CcSEcCtD
Bupropion—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	7.04e-05	0.000544	CcSEcCtD
Bupropion—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	7.04e-05	0.000544	CcSEcCtD
Bupropion—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	7.03e-05	0.000543	CcSEcCtD
Bupropion—Pruritus—Tiotropium—chronic obstructive pulmonary disease	7.01e-05	0.000542	CcSEcCtD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.99e-05	0.00154	CbGpPWpGaD
Bupropion—Injury—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000538	CcSEcCtD
Bupropion—Somnolence—Montelukast—chronic obstructive pulmonary disease	6.96e-05	0.000538	CcSEcCtD
Bupropion—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.95e-05	0.000537	CcSEcCtD
Bupropion—Weight increased—Prednisolone—chronic obstructive pulmonary disease	6.93e-05	0.000536	CcSEcCtD
Bupropion—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.9e-05	0.000533	CcSEcCtD
Bupropion—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.9e-05	0.000533	CcSEcCtD
Bupropion—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	6.89e-05	0.000533	CcSEcCtD
Bupropion—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.89e-05	0.000533	CcSEcCtD
Bupropion—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.89e-05	0.000533	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.88e-05	0.000532	CcSEcCtD
Bupropion—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	6.88e-05	0.00152	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.85e-05	0.00151	CbGpPWpGaD
Bupropion—Constipation—Formoterol—chronic obstructive pulmonary disease	6.84e-05	0.000528	CcSEcCtD
Bupropion—Pain—Arformoterol—chronic obstructive pulmonary disease	6.84e-05	0.000528	CcSEcCtD
Bupropion—Pain—Formoterol—chronic obstructive pulmonary disease	6.84e-05	0.000528	CcSEcCtD
Bupropion—Constipation—Arformoterol—chronic obstructive pulmonary disease	6.84e-05	0.000528	CcSEcCtD
Bupropion—Insomnia—Salbutamol—chronic obstructive pulmonary disease	6.83e-05	0.000528	CcSEcCtD
Bupropion—Increased appetite—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000527	CcSEcCtD
Bupropion—Amnesia—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000527	CcSEcCtD
Bupropion—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	6.78e-05	0.000524	CcSEcCtD
Bupropion—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.76e-05	0.000523	CcSEcCtD
Bupropion—Fatigue—Montelukast—chronic obstructive pulmonary disease	6.75e-05	0.000522	CcSEcCtD
Bupropion—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	6.73e-05	0.00052	CcSEcCtD
Bupropion—Somnolence—Salbutamol—chronic obstructive pulmonary disease	6.71e-05	0.000519	CcSEcCtD
Bupropion—Pain—Montelukast—chronic obstructive pulmonary disease	6.7e-05	0.000518	CcSEcCtD
Bupropion—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	6.69e-05	0.000517	CcSEcCtD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.69e-05	0.00148	CbGpPWpGaD
Bupropion—Vomiting—Aminophylline—chronic obstructive pulmonary disease	6.68e-05	0.000516	CcSEcCtD
Bupropion—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	6.67e-05	0.00147	CbGpPWpGaD
Bupropion—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	6.66e-05	0.000514	CcSEcCtD
Bupropion—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	6.66e-05	0.000514	CcSEcCtD
Bupropion—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	6.65e-05	0.000514	CcSEcCtD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.63e-05	0.00146	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	6.63e-05	0.00146	CbGpPWpGaD
Bupropion—Rash—Aminophylline—chronic obstructive pulmonary disease	6.62e-05	0.000512	CcSEcCtD
Bupropion—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	6.62e-05	0.000511	CcSEcCtD
Bupropion—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	6.6e-05	0.00051	CcSEcCtD
Bupropion—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	6.59e-05	0.000509	CcSEcCtD
Bupropion—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	6.59e-05	0.000509	CcSEcCtD
Bupropion—Headache—Aminophylline—chronic obstructive pulmonary disease	6.58e-05	0.000509	CcSEcCtD
Bupropion—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	6.56e-05	0.000507	CcSEcCtD
Bupropion—Dizziness—Tiotropium—chronic obstructive pulmonary disease	6.55e-05	0.000506	CcSEcCtD
Bupropion—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	6.54e-05	0.000505	CcSEcCtD
Bupropion—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	6.54e-05	0.000505	CcSEcCtD
Bupropion—Lethargy—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000505	CcSEcCtD
Bupropion—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	6.52e-05	0.000504	CcSEcCtD
Bupropion—Fatigue—Salbutamol—chronic obstructive pulmonary disease	6.51e-05	0.000503	CcSEcCtD
Bupropion—Pain—Salbutamol—chronic obstructive pulmonary disease	6.46e-05	0.000499	CcSEcCtD
Bupropion—Constipation—Salbutamol—chronic obstructive pulmonary disease	6.46e-05	0.000499	CcSEcCtD
Bupropion—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	6.4e-05	0.000495	CcSEcCtD
Bupropion—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000495	CcSEcCtD
Bupropion—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000495	CcSEcCtD
Bupropion—Urticaria—Arformoterol—chronic obstructive pulmonary disease	6.35e-05	0.000491	CcSEcCtD
Bupropion—Urticaria—Formoterol—chronic obstructive pulmonary disease	6.35e-05	0.000491	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.34e-05	0.0014	CbGpPWpGaD
Bupropion—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	6.32e-05	0.000488	CcSEcCtD
Bupropion—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	6.32e-05	0.000488	CcSEcCtD
Bupropion—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	6.32e-05	0.000488	CcSEcCtD
Bupropion—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	6.32e-05	0.000488	CcSEcCtD
Bupropion—Affect lability—Prednisone—chronic obstructive pulmonary disease	6.3e-05	0.000487	CcSEcCtD
Bupropion—Vomiting—Tiotropium—chronic obstructive pulmonary disease	6.3e-05	0.000487	CcSEcCtD
Bupropion—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.28e-05	0.00139	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	6.28e-05	0.00139	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	6.28e-05	0.00139	CbGpPWpGaD
Bupropion—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000483	CcSEcCtD
Bupropion—Rash—Tiotropium—chronic obstructive pulmonary disease	6.25e-05	0.000483	CcSEcCtD
Bupropion—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	6.24e-05	0.000482	CcSEcCtD
Bupropion—Nausea—Aminophylline—chronic obstructive pulmonary disease	6.24e-05	0.000482	CcSEcCtD
Bupropion—Urticaria—Montelukast—chronic obstructive pulmonary disease	6.22e-05	0.000481	CcSEcCtD
Bupropion—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	6.22e-05	0.000481	CcSEcCtD
Bupropion—Headache—Tiotropium—chronic obstructive pulmonary disease	6.21e-05	0.00048	CcSEcCtD
Bupropion—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	6.19e-05	0.00137	CbGpPWpGaD
Bupropion—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	6.19e-05	0.000478	CcSEcCtD
Bupropion—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	6.19e-05	0.000478	CcSEcCtD
Bupropion—Face oedema—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000478	CcSEcCtD
Bupropion—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	6.17e-05	0.000477	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.15e-05	0.00136	CbGpPWpGaD
Bupropion—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	6.13e-05	0.000473	CcSEcCtD
Bupropion—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	6.12e-05	0.00135	CbGpPWpGaD
Bupropion—Irritability—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000472	CcSEcCtD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	6.11e-05	0.00135	CbGpPWpGaD
Bupropion—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	6.1e-05	0.000471	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.08e-05	0.00134	CbGpPWpGaD
Bupropion—Mood swings—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000469	CcSEcCtD
Bupropion—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.03e-05	0.00133	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	6.03e-05	0.00133	CbGpPWpGaD
Bupropion—Urticaria—Salbutamol—chronic obstructive pulmonary disease	6e-05	0.000464	CcSEcCtD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6e-05	0.00132	CbGpPWpGaD
Bupropion—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	5.97e-05	0.000461	CcSEcCtD
Bupropion—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	5.97e-05	0.000461	CcSEcCtD
Bupropion—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.96e-05	0.00131	CbGpPWpGaD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.94e-05	0.00131	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	5.94e-05	0.00131	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.00131	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.00131	CbGpPWpGaD
Bupropion—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.89e-05	0.000455	CcSEcCtD
Bupropion—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.89e-05	0.000455	CcSEcCtD
Bupropion—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.89e-05	0.000455	CcSEcCtD
Bupropion—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.88e-05	0.0013	CbGpPWpGaD
Bupropion—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.000454	CcSEcCtD
Bupropion—Dry skin—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000454	CcSEcCtD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.87e-05	0.00129	CbGpPWpGaD
Bupropion—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.77e-05	0.000446	CcSEcCtD
Bupropion—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.74e-05	0.000443	CcSEcCtD
Bupropion—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.74e-05	0.000443	CcSEcCtD
Bupropion—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.66e-05	0.000437	CcSEcCtD
Bupropion—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.66e-05	0.000437	CcSEcCtD
Bupropion—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000436	CcSEcCtD
Bupropion—Asthenia—Montelukast—chronic obstructive pulmonary disease	5.62e-05	0.000434	CcSEcCtD
Bupropion—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000431	CcSEcCtD
Bupropion—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	5.56e-05	0.00043	CcSEcCtD
Bupropion—Pruritus—Montelukast—chronic obstructive pulmonary disease	5.54e-05	0.000428	CcSEcCtD
Bupropion—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	5.54e-05	0.00122	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.52e-05	0.00122	CbGpPWpGaD
Bupropion—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	5.47e-05	0.000423	CcSEcCtD
Bupropion—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	5.47e-05	0.000423	CcSEcCtD
Bupropion—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	5.45e-05	0.000421	CcSEcCtD
Bupropion—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000419	CcSEcCtD
Bupropion—Asthenia—Salbutamol—chronic obstructive pulmonary disease	5.42e-05	0.000419	CcSEcCtD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	5.4e-05	0.00119	CbGpPWpGaD
Bupropion—Sweating increased—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.000417	CcSEcCtD
Bupropion—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	5.36e-05	0.000414	CcSEcCtD
Bupropion—Pruritus—Salbutamol—chronic obstructive pulmonary disease	5.34e-05	0.000413	CcSEcCtD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.32e-05	0.00117	CbGpPWpGaD
Bupropion—Dizziness—Formoterol—chronic obstructive pulmonary disease	5.29e-05	0.000409	CcSEcCtD
Bupropion—Dizziness—Arformoterol—chronic obstructive pulmonary disease	5.29e-05	0.000409	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.29e-05	0.00117	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.21e-05	0.00115	CbGpPWpGaD
Bupropion—Dizziness—Montelukast—chronic obstructive pulmonary disease	5.18e-05	0.0004	CcSEcCtD
Bupropion—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	5.17e-05	0.000399	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.15e-05	0.00114	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.11e-05	0.00113	CbGpPWpGaD
Bupropion—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000394	CcSEcCtD
Bupropion—Vomiting—Arformoterol—chronic obstructive pulmonary disease	5.08e-05	0.000393	CcSEcCtD
Bupropion—Vomiting—Formoterol—chronic obstructive pulmonary disease	5.08e-05	0.000393	CcSEcCtD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.08e-05	0.00112	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.04e-05	0.00111	CbGpPWpGaD
Bupropion—Rash—Arformoterol—chronic obstructive pulmonary disease	5.04e-05	0.00039	CcSEcCtD
Bupropion—Rash—Formoterol—chronic obstructive pulmonary disease	5.04e-05	0.00039	CcSEcCtD
Bupropion—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	5.04e-05	0.000389	CcSEcCtD
Bupropion—Dermatitis—Formoterol—chronic obstructive pulmonary disease	5.04e-05	0.000389	CcSEcCtD
Bupropion—Weight increased—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.000389	CcSEcCtD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.01e-05	0.00111	CbGpPWpGaD
Bupropion—Headache—Formoterol—chronic obstructive pulmonary disease	5.01e-05	0.000387	CcSEcCtD
Bupropion—Headache—Arformoterol—chronic obstructive pulmonary disease	5.01e-05	0.000387	CcSEcCtD
Bupropion—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.01e-05	0.00111	CbGpPWpGaD
Bupropion—Weight decreased—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000387	CcSEcCtD
Bupropion—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	5e-05	0.000386	CcSEcCtD
Bupropion—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.99e-05	0.000386	CcSEcCtD
Bupropion—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000386	CcSEcCtD
Bupropion—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.98e-05	0.000385	CcSEcCtD
Bupropion—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.94e-05	0.00109	CbGpPWpGaD
Bupropion—Rash—Montelukast—chronic obstructive pulmonary disease	4.94e-05	0.000382	CcSEcCtD
Bupropion—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.93e-05	0.000381	CcSEcCtD
Bupropion—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	4.92e-05	0.00038	CcSEcCtD
Bupropion—Headache—Montelukast—chronic obstructive pulmonary disease	4.91e-05	0.000379	CcSEcCtD
Bupropion—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000376	CcSEcCtD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.86e-05	0.00107	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.86e-05	0.00107	CbGpPWpGaD
Bupropion—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.85e-05	0.00107	CbGpPWpGaD
Bupropion—Angioedema—Prednisolone—chronic obstructive pulmonary disease	4.85e-05	0.000375	CcSEcCtD
Bupropion—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000374	CcSEcCtD
Bupropion—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000374	CcSEcCtD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.82e-05	0.00106	CbGpPWpGaD
Bupropion—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.8e-05	0.000371	CcSEcCtD
Bupropion—Malaise—Prednisolone—chronic obstructive pulmonary disease	4.78e-05	0.00037	CcSEcCtD
Bupropion—Vertigo—Prednisolone—chronic obstructive pulmonary disease	4.77e-05	0.000368	CcSEcCtD
Bupropion—Rash—Salbutamol—chronic obstructive pulmonary disease	4.76e-05	0.000368	CcSEcCtD
Bupropion—Syncope—Prednisolone—chronic obstructive pulmonary disease	4.76e-05	0.000368	CcSEcCtD
Bupropion—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.76e-05	0.000368	CcSEcCtD
Bupropion—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.75e-05	0.000367	CcSEcCtD
Bupropion—Nausea—Formoterol—chronic obstructive pulmonary disease	4.75e-05	0.000367	CcSEcCtD
Bupropion—Headache—Salbutamol—chronic obstructive pulmonary disease	4.73e-05	0.000366	CcSEcCtD
Bupropion—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	4.66e-05	0.00036	CcSEcCtD
Bupropion—Nausea—Montelukast—chronic obstructive pulmonary disease	4.65e-05	0.00036	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.6e-05	0.00102	CbGpPWpGaD
Bupropion—Convulsion—Prednisolone—chronic obstructive pulmonary disease	4.6e-05	0.000355	CcSEcCtD
Bupropion—Hypertension—Prednisolone—chronic obstructive pulmonary disease	4.58e-05	0.000354	CcSEcCtD
Bupropion—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.48e-05	0.000347	CcSEcCtD
Bupropion—Discomfort—Prednisolone—chronic obstructive pulmonary disease	4.46e-05	0.000345	CcSEcCtD
Bupropion—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.000344	CcSEcCtD
Bupropion—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000342	CcSEcCtD
Bupropion—Hallucination—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000341	CcSEcCtD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.37e-05	0.000965	CbGpPWpGaD
Bupropion—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000336	CcSEcCtD
Bupropion—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	4.33e-05	0.000335	CcSEcCtD
Bupropion—Oedema—Prednisolone—chronic obstructive pulmonary disease	4.33e-05	0.000335	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.33e-05	0.000955	CbGpPWpGaD
Bupropion—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	4.29e-05	0.000947	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.28e-05	0.000944	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.27e-05	0.000942	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.26e-05	0.000941	CbGpPWpGaD
Bupropion—Shock—Prednisolone—chronic obstructive pulmonary disease	4.26e-05	0.000329	CcSEcCtD
Bupropion—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.24e-05	0.000935	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.23e-05	0.000933	CbGpPWpGaD
Bupropion—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	4.23e-05	0.000327	CcSEcCtD
Bupropion—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.21e-05	0.000928	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.19e-05	0.000925	CbGpPWpGaD
Bupropion—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	4.19e-05	0.000324	CcSEcCtD
Bupropion—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.18e-05	0.000922	CbGpPWpGaD
Bupropion—Eye disorder—Prednisone—chronic obstructive pulmonary disease	4.14e-05	0.00032	CcSEcCtD
Bupropion—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.12e-05	0.000909	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.12e-05	0.000909	CbGpPWpGaD
Bupropion—Flushing—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000318	CcSEcCtD
Bupropion—Angiopathy—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000311	CcSEcCtD
Bupropion—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000309	CcSEcCtD
Bupropion—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.000306	CcSEcCtD
Bupropion—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.94e-05	0.00087	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.92e-05	0.000865	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.92e-05	0.000865	CbGpPWpGaD
Bupropion—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.92e-05	0.000303	CcSEcCtD
Bupropion—Alopecia—Prednisone—chronic obstructive pulmonary disease	3.91e-05	0.000302	CcSEcCtD
Bupropion—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.89e-05	0.0003	CcSEcCtD
Bupropion—Mental disorder—Prednisone—chronic obstructive pulmonary disease	3.88e-05	0.0003	CcSEcCtD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.87e-05	0.000854	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.86e-05	0.000853	CbGpPWpGaD
Bupropion—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.86e-05	0.000298	CcSEcCtD
Bupropion—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.84e-05	0.000847	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.79e-05	0.000835	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.71e-05	0.00082	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	3.7e-05	0.000817	CbGpPWpGaD
Bupropion—Pain—Prednisolone—chronic obstructive pulmonary disease	3.7e-05	0.000286	CcSEcCtD
Bupropion—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.66e-05	0.000809	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.66e-05	0.000808	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.64e-05	0.000803	CbGpPWpGaD
Bupropion—Vision blurred—Prednisone—chronic obstructive pulmonary disease	3.63e-05	0.000281	CcSEcCtD
Bupropion—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.62e-05	0.000799	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.61e-05	0.000797	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.59e-05	0.000792	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.58e-05	0.00079	CbGpPWpGaD
Bupropion—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	3.58e-05	0.000276	CcSEcCtD
Bupropion—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	3.57e-05	0.000276	CcSEcCtD
Bupropion—Anaemia—Prednisone—chronic obstructive pulmonary disease	3.56e-05	0.000275	CcSEcCtD
Bupropion—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.56e-05	0.000786	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.55e-05	0.000784	CbGpPWpGaD
Bupropion—Agitation—Prednisone—chronic obstructive pulmonary disease	3.54e-05	0.000274	CcSEcCtD
Bupropion—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.52e-05	0.000272	CcSEcCtD
Bupropion—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.52e-05	0.000777	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.5e-05	0.000773	CbGpPWpGaD
Bupropion—Malaise—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000269	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.48e-05	0.000767	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.47e-05	0.000767	CbGpPWpGaD
Bupropion—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000268	CcSEcCtD
Bupropion—Syncope—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000267	CcSEcCtD
Bupropion—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.44e-05	0.000266	CcSEcCtD
Bupropion—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	3.39e-05	0.000262	CcSEcCtD
Bupropion—Convulsion—Prednisone—chronic obstructive pulmonary disease	3.34e-05	0.000258	CcSEcCtD
Bupropion—Hypertension—Prednisone—chronic obstructive pulmonary disease	3.33e-05	0.000257	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.32e-05	0.000732	CbGpPWpGaD
Bupropion—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.28e-05	0.000254	CcSEcCtD
Bupropion—Myalgia—Prednisone—chronic obstructive pulmonary disease	3.28e-05	0.000254	CcSEcCtD
Bupropion—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.27e-05	0.000722	CbGpPWpGaD
Bupropion—Anxiety—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000253	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000252	CcSEcCtD
Bupropion—Discomfort—Prednisone—chronic obstructive pulmonary disease	3.24e-05	0.000251	CcSEcCtD
Bupropion—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	3.19e-05	0.000247	CcSEcCtD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.18e-05	0.000701	CbGpPWpGaD
Bupropion—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	3.15e-05	0.000243	CcSEcCtD
Bupropion—Oedema—Prednisone—chronic obstructive pulmonary disease	3.15e-05	0.000243	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000694	CbGpPWpGaD
Bupropion—Infection—Prednisone—chronic obstructive pulmonary disease	3.13e-05	0.000242	CcSEcCtD
Bupropion—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.1e-05	0.000684	CbGpPWpGaD
Bupropion—Shock—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.000239	CcSEcCtD
Bupropion—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.09e-05	0.000238	CcSEcCtD
Bupropion—Tachycardia—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000237	CcSEcCtD
Bupropion—Skin disorder—Prednisone—chronic obstructive pulmonary disease	3.06e-05	0.000236	CcSEcCtD
Bupropion—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.05e-05	0.000673	CbGpPWpGaD
Bupropion—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	3.04e-05	0.000235	CcSEcCtD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.04e-05	0.000671	CbGpPWpGaD
Bupropion—Anorexia—Prednisone—chronic obstructive pulmonary disease	3e-05	0.000232	CcSEcCtD
Bupropion—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	2.99e-05	0.00066	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.98e-05	0.000658	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.96e-05	0.000654	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.94e-05	0.000649	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.94e-05	0.000648	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	2.93e-05	0.000646	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.92e-05	0.000645	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.9e-05	0.000639	CbGpPWpGaD
Bupropion—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.87e-05	0.000222	CcSEcCtD
Bupropion—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.86e-05	0.000221	CcSEcCtD
Bupropion—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.85e-05	0.00022	CcSEcCtD
Bupropion—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.83e-05	0.000218	CcSEcCtD
Bupropion—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.8e-05	0.000617	CbGpPWpGaD
Bupropion—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.77e-05	0.000214	CcSEcCtD
Bupropion—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.76e-05	0.00061	CbGpPWpGaD
Bupropion—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	2.74e-05	0.000211	CcSEcCtD
Bupropion—Rash—Prednisolone—chronic obstructive pulmonary disease	2.73e-05	0.000211	CcSEcCtD
Bupropion—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.73e-05	0.000211	CcSEcCtD
Bupropion—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.72e-05	0.000601	CbGpPWpGaD
Bupropion—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.71e-05	0.00021	CcSEcCtD
Bupropion—Headache—Prednisolone—chronic obstructive pulmonary disease	2.71e-05	0.00021	CcSEcCtD
Bupropion—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.7e-05	0.000596	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.7e-05	0.000596	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.7e-05	0.000596	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.69e-05	0.000594	CbGpPWpGaD
Bupropion—Constipation—Prednisone—chronic obstructive pulmonary disease	2.69e-05	0.000208	CcSEcCtD
Bupropion—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.69e-05	0.000593	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.66e-05	0.000588	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.65e-05	0.000584	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.65e-05	0.000584	CbGpPWpGaD
Bupropion—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.59e-05	0.0002	CcSEcCtD
Bupropion—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.00057	CbGpPWpGaD
Bupropion—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.57e-05	0.000199	CcSEcCtD
Bupropion—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.57e-05	0.000199	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.57e-05	0.000568	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.56e-05	0.000565	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.55e-05	0.000562	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.55e-05	0.000562	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.53e-05	0.000558	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.52e-05	0.000557	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.52e-05	0.000557	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.52e-05	0.000557	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.51e-05	0.000554	CbGpPWpGaD
Bupropion—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.5e-05	0.000193	CcSEcCtD
Bupropion—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000192	CcSEcCtD
Bupropion—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.49e-05	0.000192	CcSEcCtD
Bupropion—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.48e-05	0.000546	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.45e-05	0.000541	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	2.39e-05	0.000527	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.32e-05	0.000513	CbGpPWpGaD
Bupropion—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.32e-05	0.000179	CcSEcCtD
Bupropion—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.31e-05	0.000509	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.29e-05	0.000506	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.28e-05	0.000503	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.28e-05	0.000502	CbGpPWpGaD
Bupropion—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.26e-05	0.000174	CcSEcCtD
Bupropion—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.26e-05	0.000498	CbGpPWpGaD
Bupropion—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000172	CcSEcCtD
Bupropion—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.22e-05	0.00049	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.19e-05	0.000483	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.16e-05	0.000476	CbGpPWpGaD
Bupropion—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.15e-05	0.000166	CcSEcCtD
Bupropion—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.08e-05	0.000161	CcSEcCtD
Bupropion—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.08e-05	0.000458	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.06e-05	0.000454	CbGpPWpGaD
Bupropion—Vomiting—Prednisone—chronic obstructive pulmonary disease	2e-05	0.000155	CcSEcCtD
Bupropion—Rash—Prednisone—chronic obstructive pulmonary disease	1.98e-05	0.000153	CcSEcCtD
Bupropion—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.98e-05	0.000153	CcSEcCtD
Bupropion—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000437	CbGpPWpGaD
Bupropion—Headache—Prednisone—chronic obstructive pulmonary disease	1.97e-05	0.000152	CcSEcCtD
Bupropion—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.94e-05	0.000428	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.94e-05	0.000428	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000425	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.91e-05	0.000422	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.000416	CbGpPWpGaD
Bupropion—Nausea—Prednisone—chronic obstructive pulmonary disease	1.87e-05	0.000144	CcSEcCtD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000398	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000395	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.78e-05	0.000393	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.76e-05	0.000388	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.76e-05	0.000388	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.75e-05	0.000387	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000373	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.68e-05	0.00037	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.66e-05	0.000367	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000367	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.63e-05	0.00036	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.54e-05	0.000341	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.000334	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.47e-05	0.000324	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.38e-05	0.000304	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000302	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.36e-05	0.000301	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.36e-05	0.0003	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.35e-05	0.000299	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.34e-05	0.000295	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.33e-05	0.000293	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.3e-05	0.000288	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.29e-05	0.000284	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000277	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.24e-05	0.000275	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.23e-05	0.000272	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000267	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.00026	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.17e-05	0.000257	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.13e-05	0.00025	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000239	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.05e-05	0.000233	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000232	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000229	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000227	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000225	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.83e-06	0.000217	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.49e-06	0.000209	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.3e-06	0.000205	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.04e-06	0.000199	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9e-06	0.000199	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.91e-06	0.000197	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.91e-06	0.000197	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.8e-06	0.000194	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.75e-06	0.000193	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.74e-06	0.000193	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.56e-06	0.000189	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.4e-06	0.000185	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.31e-06	0.000183	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.21e-06	0.000181	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.14e-06	0.00018	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.03e-06	0.000177	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.87e-06	0.000174	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.4e-06	0.000163	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.31e-06	0.000161	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.29e-06	0.000161	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.25e-06	0.00016	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.23e-06	0.00016	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.19e-06	0.000159	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.17e-06	0.000158	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.14e-06	0.000158	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.04e-06	0.000155	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.7e-06	0.000148	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.68e-06	0.000147	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.6e-06	0.000146	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.56e-06	0.000145	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.54e-06	0.000144	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.35e-06	0.00014	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.22e-06	0.000137	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.19e-06	0.000137	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.17e-06	0.000136	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.12e-06	0.000135	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.09e-06	0.000134	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.08e-06	0.000134	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.02e-06	0.000133	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.71e-06	0.000126	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.67e-06	0.000125	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.59e-06	0.000123	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.38e-06	0.000119	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	5.35e-06	0.000118	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.12e-06	0.000113	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.07e-06	0.000112	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.02e-06	0.000111	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5e-06	0.00011	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.96e-06	0.000109	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.78e-06	0.000106	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.73e-06	0.000104	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.66e-06	0.000103	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.62e-06	0.000102	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.42e-06	9.74e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.38e-06	9.66e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.32e-06	9.53e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.31e-06	9.52e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.29e-06	9.48e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.23e-06	9.34e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.23e-06	9.33e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.13e-06	9.12e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.05e-06	8.93e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.97e-06	8.77e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.95e-06	8.71e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.74e-06	8.25e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.66e-06	8.07e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.5e-06	7.72e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.31e-06	7.31e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.27e-06	7.21e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.05e-06	6.72e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3e-06	6.62e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.98e-06	6.57e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.89e-06	6.37e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.87e-06	6.34e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.85e-06	6.28e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.54e-06	5.61e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.43e-06	5.37e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.96e-06	4.33e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.88e-06	4.14e-05	CbGpPWpGaD
